145 related articles for article (PubMed ID: 17575121)
1. Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer.
Yang L; Amann JM; Kikuchi T; Porta R; Guix M; Gonzalez A; Park KH; Billheimer D; Arteaga CL; Tai HH; DuBois R; Carbone DP; Johnson DH
Cancer Res; 2007 Jun; 67(12):5587-93. PubMed ID: 17575121
[TBL] [Abstract][Full Text] [Related]
2. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.
Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P
Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207
[TBL] [Abstract][Full Text] [Related]
3. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
Yoshida T; Song L; Bai Y; Kinose F; Li J; Ohaegbulam KC; Muñoz-Antonia T; Qu X; Eschrich S; Uramoto H; Tanaka F; Nasarre P; Gemmill RM; Roche J; Drabkin HA; Haura EB
PLoS One; 2016; 11(1):e0147344. PubMed ID: 26789630
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer.
Dohadwala M; Yang SC; Luo J; Sharma S; Batra RK; Huang M; Lin Y; Goodglick L; Krysan K; Fishbein MC; Hong L; Lai C; Cameron RB; Gemmill RM; Drabkin HA; Dubinett SM
Cancer Res; 2006 May; 66(10):5338-45. PubMed ID: 16707460
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
[TBL] [Abstract][Full Text] [Related]
6. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer.
Ding Y; Tong M; Liu S; Moscow JA; Tai HH
Carcinogenesis; 2005 Jan; 26(1):65-72. PubMed ID: 15358636
[TBL] [Abstract][Full Text] [Related]
7. Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic tumors.
Pham H; Chen M; Li A; King J; Angst E; Dawson DW; Park J; Reber HA; Hines OJ; Eibl G
Pancreas; 2010 Apr; 39(3):332-9. PubMed ID: 19820419
[TBL] [Abstract][Full Text] [Related]
8. The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-Met inhibition.
Nakachi I; Naoki K; Soejima K; Kawada I; Watanabe H; Yasuda H; Nakayama S; Yoda S; Satomi R; Ikemura S; Terai H; Sato T; Ishizaka A
Mol Cancer Res; 2010 Aug; 8(8):1142-51. PubMed ID: 20647329
[TBL] [Abstract][Full Text] [Related]
9. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer.
Hughes D; Otani T; Yang P; Newman RA; Yantiss RK; Altorki NK; Port JL; Yan M; Markowitz SD; Mazumdar M; Tai HH; Subbaramaiah K; Dannenberg AJ
Cancer Prev Res (Phila); 2008 Sep; 1(4):241-9. PubMed ID: 19138967
[TBL] [Abstract][Full Text] [Related]
10. Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells.
Hazra S; Dubinett SM
Prostaglandins Leukot Essent Fatty Acids; 2007 Jul; 77(1):51-8. PubMed ID: 17697767
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with erlotinib and a transforming growth factor-β type I receptor inhibitor effectively suppresses the enhanced motility of erlotinib-resistant non-small-cell lung cancer cells.
Serizawa M; Takahashi T; Yamamoto N; Koh Y
J Thorac Oncol; 2013 Mar; 8(3):259-69. PubMed ID: 23334091
[TBL] [Abstract][Full Text] [Related]
12. IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer.
Cui X; Yang SC; Sharma S; Heuze-Vourc'h N; Dubinett SM
Biochem Biophys Res Commun; 2006 May; 343(4):995-1001. PubMed ID: 16574063
[TBL] [Abstract][Full Text] [Related]
13. Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase.
Han S; Sidell N; Roman J
Cancer Lett; 2005 Feb; 219(1):71-81. PubMed ID: 15694666
[TBL] [Abstract][Full Text] [Related]
14. Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression.
Mann JR; Backlund MG; Buchanan FG; Daikoku T; Holla VR; Rosenberg DW; Dey SK; DuBois RN
Cancer Res; 2006 Jul; 66(13):6649-56. PubMed ID: 16818638
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E
Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide phosphoribosyltransferase: a potent therapeutic target in non-small cell lung cancer with epidermal growth factor receptor-gene mutation.
Okumura S; Sasaki T; Minami Y; Ohsaki Y
J Thorac Oncol; 2012 Jan; 7(1):49-56. PubMed ID: 22089115
[TBL] [Abstract][Full Text] [Related]
17. Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.
Witta SE; Gemmill RM; Hirsch FR; Coldren CD; Hedman K; Ravdel L; Helfrich B; Dziadziuszko R; Chan DC; Sugita M; Chan Z; Baron A; Franklin W; Drabkin HA; Girard L; Gazdar AF; Minna JD; Bunn PA
Cancer Res; 2006 Jan; 66(2):944-50. PubMed ID: 16424029
[TBL] [Abstract][Full Text] [Related]
18. Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes.
Miyaki A; Yang P; Tai HH; Subbaramaiah K; Dannenberg AJ
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G559-66. PubMed ID: 19608733
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells.
Giovannetti E; Lemos C; Tekle C; Smid K; Nannizzi S; Rodriguez JA; Ricciardi S; Danesi R; Giaccone G; Peters GJ
Mol Pharmacol; 2008 Apr; 73(4):1290-300. PubMed ID: 18187583
[TBL] [Abstract][Full Text] [Related]
20. 15-Deoxy-Δ12,14-prostaglandin J2 induces expression of 15-hydroxyprostaglandin dehydrogenase through Elk-1 activation in human breast cancer MDA-MB-231 cells.
Kim HR; Lee HN; Lim K; Surh YJ; Na HK
Mutat Res; 2014 Oct; 768():6-15. PubMed ID: 25773924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
